Biological E gets drug regulator's approval to conduct phase 2/3 trials on children
Sep 02, 2021
New Delhi [India], September 2 : The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain conditions, sources told ANI.